Acute Ischemic Stroke: Epidemiology Forecast to 2027

A stroke occurs when blood to the brain is either blocked or interrupted by blood clots or ruptured blood vessels; this deprives the brain of oxygen and nutrients, ultimately leading to the death of brain cells. Acute ischemic stroke (AIS) occurs due to an obstructed blood vessel that supplies blood to the brain, and is the predominant type of stroke, accounting for approximately 65–90% of stroke cases across the US, Europe, and Asia. The major risk factors associated with the development of AIS include both modifiable and non-modifiable conditions, such as hypertension, smoking, diabetes mellitus, obesity, age, and family history of stroke.

GlobalData epidemiologists utilized comprehensive, country-specific data from national stoke registries and peer-reviewed journal articles when available, to arrive at a meaningful, in-depth analysis and forecast of first-ever diagnosed incident cases of AIS, diagnosed prevalent cases of AIS, and mortality of AIS. Moreover, GlobalData epidemiologists provide detailed, clinically relevant segmentations for first-ever diagnosed incident cases of AIS. Finally, uniform methodology was used across the 8MM to ensure meaningful comparisons across markets. Additional segmentations on AIS and transient ischemic attacks can be found in the GlobalData AIS Epidemiology Forecast Model.

GlobalData epidemiologists forecast that the first-ever diagnosed incident cases of AIS in the 8MM will grow by an annual growth rate (AGR) of 4.43%, from 2,570,175 cases in 2017 to 3,708,465 cases in 2027. In the 8MM in 2017, urban China had the highest number of first-ever diagnosed incident cases with 1,735,727, while the UK had the lowest number of first-ever diagnosed incident cases with 50,803. Additionally, GlobalData epidemiologists forecast that the diagnosed prevalent cases of AIS in the 8MM will grow by an AGR of 2.76%, from 17,968,771 cases in 2017 to 22,931,332 cases in 2027. In the 8MM in 2017, the US had the highest number of diagnosed prevalent cases with 6,760,839, while Spain had the lowest number of diagnosed prevalent cases with 346,779.

Scope

The Acute Ischemic Stroke (AIS) Epidemiology Forecast Report and Epidemiology Forecast Model provide an overview of the risk factors and global trends of AIS in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and urban China).

This report also includes a 10-year epidemiological forecast for first-ever diagnosed incident cases of AIS, diagnosed prevalent cases of AIS, and mortality of AIS. First-ever diagnosed incident cases are further segmented by age (18 to 85 years and older), sex, recurrence, and Trial of Org 10172 in Acute Stroke Treatment (TOAST) subtype (large-artery atherosclerosis, cardioembolism, small-artery occlusion, other determined cause, undetermined cause [cryptogenic]), while diagnosed prevalent cases are further segmented by age (18 to 85 years and older) and sex.

The Acute Ischemic Stroke epidemiology forecast report and model were written and developed by Masters- and PhD-level epidemiologists.

The Epidemiology Forecast Report is in-depth, high quality, transparent, and market-driven, providing expert analysis of disease trends in the 8MM.

The Epidemiology Forecast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Reasons to buy

The Acute Ischemic Stroke (AIS) Epidemiology Forecast series will allow you to:

Develop business strategies by understanding the trends shaping and driving the global AIS market.

Quantify patient populations in the global AIS market to improve product design, pricing, and launch plans.

Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for AIS therapeutics in each of the markets covered.

Understand magnitude of AIS population by recurrence, subtype, and mortality.

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Acute Ischemic Stroke: Executive Summary

2.1 Related Reports

2 ...

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Acute Ischemic Stroke: Executive Summary

2.1 Related Reports

2.2 Upcoming Reports

3 Epidemiology

3.1 Disease Background

3.2 Risk Factors and Comorbidities

3.3 Global and Historical Trends

3.4 Forecast Methodology

3.4.1 Sources

3.4.2 Forecast Assumptions and Methods

3.5 Epidemiological Forecast for AIS (2017–2027)

3.5.1 First-Ever Diagnosed Incident Cases of AIS

3.5.2 Age-Specific First-Ever Diagnosed Incident Cases of AIS

3.5.3 Sex-Specific First-Ever Diagnosed Incident Cases of AIS

3.5.4 Recurrent Diagnosed Incident Cases of AIS

3.5.5 First-Ever Diagnosed Incident Cases of AIS by TOAST Subtype

3.5.6 Diagnosed Prevalent Cases of AIS

3.5.7 Age-Specific Diagnosed Prevalent Cases of AIS

3.5.8 Sex-Specific Diagnosed Prevalent Cases of AIS

3.5.9 AIS Mortality

3.6 Discussion

3.6.1 Epidemiological Forecast Insight

3.6.2 Limitations of Analysis

3.6.3 Strengths of Analysis

4 Appendix

4.1 Bibliography

4.2 About the Authors

4.2.1 Epidemiologist

4.2.2 Reviewers

4.2.3 Global Director of Therapy Analysis and Epidemiology

4.2.4 Global Head and EVP of Healthcare Operations and Strategy

4.3 About GlobalData

4.4 Contact Us

4.5 Disclaimer

List of Tables

Table 1: Risk Factors and Comorbidities for AIS

Table 1: Risk Factors and Comorbidities for AIS

List of Figures

Figure 1: 8MM, Diagnosed Incident Cases of First-Ever AIS, Men and Women, Ages ≥18 Years, 2017 and 2027

Figure 2: 8MM, Diagnosed Prevalent Cases of ...

Figure 1: 8MM, Diagnosed Incident Cases of First-Ever AIS, Men and Women, Ages ≥18 Years, 2017 and 2027

Figure 2: 8MM, Diagnosed Prevalent Cases of AIS, Men and Women, Ages ≥18 Years, 2017 and 2027

Figure 3: 8MM, Age-Standardized First-Ever Diagnosed Incidence of AIS, Men, Ages ≥18 Years, 2007–2027

Figure 4: 8MM, Age-Standardized First-Ever Diagnosed Incidence of AIS, Women, Ages ≥18 Years, 2007–2027

Figure 5: 8MM, Age-Standardized Diagnosed Prevalence of AIS, Men, Ages ≥18 Years, 2007–2027

Figure 6: 8MM, Age-Standardized Diagnosed Prevalence of AIS, Women, Ages ≥18 Years, 2007–2027

Figure 7: Sources Used and Not Used for First-Ever Diagnosed Incident Cases of AIS

Figure 8: Sources Used and Not Used for Recurrent Diagnosed Incident Cases of AIS

Figure 9: Sources Used and Not Used for First-Ever Diagnosed Incident Cases of AIS by TOAST Subtype

Figure 10: Sources Used and Not Used for Diagnosed Prevalent Cases of AIS

Figure 11: Sources Used and Not Used for AIS Mortality

Figure 12: 8MM, First-Ever Diagnosed Incident Cases of AIS, Men and Women, Ages ≥18 Years, 2017

Figure 13: 8MM, Age-Specific First-Ever Diagnosed Incident Cases of AIS, Men and Women, 2017

Figure 14: 8MM, Sex-Specific First-Ever Diagnosed Incident Cases of AIS, Ages ≥18 Years, 2017

Figure 15: 8MM, Recurrent Diagnosed Incident Cases of AIS, Ages ≥18 Years, Men and Women, 2017

Figure 16: 8MM, First-Ever Diagnosed Incident Cases of AIS by TOAST Subtype, Ages ≥18 Years, Men and Women, 2017

Figure 17: 8MM, Diagnosed Prevalent Cases of AIS, Men and Women, Ages ≥18 Years, 2017

Figure 18: 8MM, Age-Specific Diagnosed Prevalent Cases of AIS, Men and Women, 2017

Figure 19: 8MM, Sex-Specific Diagnosed Prevalent Cases of AIS, Ages ≥18 Years, 2017

Figure 20: 8MM, AIS Mortality, Ages ≥18 Years, Men and Women, 2017

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Saved reports